Nicholas W. Morrell

Active 1994–2025

Also published as
Nicholas, W. Morrell
175
Papers
30,977
Citations
94
h-index
171
i10-index

Citations

Citations per year for Nicholas W. Morrell1960: 1 citations1997: 2 citations1998: 9 citations1999: 13 citations2000: 12 citations2001: 27 citations2002: 51 citations2003: 58 citations2004: 94 citations2005: 106 citations2006: 152 citations2007: 137 citations2008: 178 citations2009: 204 citations2010: 198 citations2011: 214 citations2012: 254 citations2013: 307 citations2014: 258 citations2015: 250 citations2016: 261 citations2017: 248 citations2018: 321 citations2019: 956 citations2020: 1,383 citations2021: 1,269 citations2022: 1,107 citations2023: 794 citations2024: 1,266 citations2025: 561 citations2026: 11 citations1961–1996: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,719 citing papers, 23.7% of this breakdownChina: 1,400 citing papers, 12.2% of this breakdownUnited Kingdom: 1,203 citing papers, 10.5% of this breakdownGermany: 725 citing papers, 6.3% of this breakdownFrance: 594 citing papers, 5.2% of this breakdownCanada: 470 citing papers, 4.1% of this breakdownNetherlands: 426 citing papers, 3.7% of this breakdownItaly: 323 citing papers, 2.8% of this breakdownJapan: 276 citing papers, 2.4% of this breakdownAustralia: 268 citing papers, 2.4% of this breakdownSpain: 243 citing papers, 2.1% of this breakdownSweden: 209 citing papers, 1.8% of this breakdown
0%23.7%Other 22.8%

Fields

  • Medicine63.6%
  • Biochemistry, Genetics and Molecular Biology29.9%
  • Immunology and Microbiology2.8%
  • Neuroscience1.1%
  • Chemistry0.6%
  • Engineering0.4%
  • Other1.6%

Topics

  • Pulmonary Hypertension Research and Treatments14.5%
  • Genetic Associations and Epidemiology2.2%
  • MicroRNA in disease regulation2.1%
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis1.9%
  • Cardiovascular Function and Risk Factors1.7%
  • Vascular Anomalies and Treatments1.7%
  • Other75.9%

Coauthors

All papers

Open in search
  1. Genomic atlas of the human plasma proteome

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , John Danesh, Heiko Runz, Adam S. Butterworth - Nature, Nat. 2018 cited by 2,468

  2. Whole-genome sequencing of patients with rare diseases in a national health system

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hugh S. Markus, Joannella Morales, Nicholas W. Morrell, Andrew Mumford, Elizabeth Ormondroyd, Stuart Rankin, Augusto Rendon, Sylvia Richardson, Irene Roberts, Noémi Roy, Moin A. Saleem, Kenneth G. C. Smith, Hannah Stark, Rhea Tan, Andreas C. Themistocleous, Adrian J. Thrasher, Hugh Watkins, Andrew R. Webster, Martin R. Wilkins, Catherine Williamson, James Whitworth, Sean Humphray, David R. Bentley, NIHR BioResource for the 100,000 Genomes Project, Stephen Abbs, Lara Abulhoul, Julian Adlard, Munaza Ahmed, Timothy J. Aitman, Hana Alachkar, David Allsup, J. P. Almeida, Philip Ancliff, Richard Antrobus, Ruth Armstrong, Gavin Arno, Sofie Ashford, William J. Astle, Anthony Attwood, Paul Aurora, Christian Babbs, Chiara Bacchelli, Tamam Bakchoul, Siddharth Banka, Tadbir K. Bariana, Julian Barwell, Joana Batista, Helen Baxendale, Phil Beales, David Bennett, David R. Bentley, Agnieszka Bierżyńska, Tina Biss, Maria Bitner‐Glindzicz, Graeme C. Black, Marta Bleda, Iulia Blesneac, Detlef Böckenhauer, Harm Jan Bogaard, Christian Bourne, Sara Boyce, John R. Bradley, Eugene Bragin, Gerome Breen, Paul Brennan, Carole Brewer, Matthew A. Brown, Andrew C. Browning, Michael J. Browning, Rachel Buchan and 412 more - Nature, Nat. 2020 cited by 582

  3. Elevated Levels of Inflammatory Cytokines Predict Survival in Idiopathic and Familial Pulmonary Arterial Hypertension

    Authors: , , , , , , , , , , , , , - Circulation 2010 cited by 807

  4. Genetics and genomics of pulmonary arterial hypertension

    Authors: , , , , , , , - European Respiratory Journal 2018 cited by 468

  5. Selective enhancement of endothelial BMPR-II with BMP9 reverses pulmonary arterial hypertension

    Authors: , , , , , , , , , , , , , , , - Nature Medicine 2015 cited by 505

  6. Molecular genetic framework underlying pulmonary arterial hypertension

    Authors: , , , - Nature Reviews Cardiology 2019 cited by 317

  7. Identification of MicroRNA-124 as a Major Regulator of Enhanced Endothelial Cell Glycolysis in Pulmonary Arterial Hypertension via PTBP1 (Polypyrimidine Tract Binding Protein) and Pyruvate Kinase M2

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Circulation 2017 cited by 262

  8. BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Respiratory Medicine 2016 cited by 451

  9. Metabolic and Proliferative State of Vascular Adventitial Fibroblasts in Pulmonary Hypertension Is Regulated Through a MicroRNA-124/PTBP1 (Polypyrimidine Tract Binding Protein 1)/Pyruvate Kinase Muscle Axis

    Authors: , , , , , , , , , , , , , , , , , - Circulation 2017 cited by 249

  10. BMPR2 Mutation and Metabolic Reprogramming in Pulmonary Arterial Hypertension

    Authors: , , - Circulation Research 2023 cited by 112

  11. Cellular and molecular pathobiology of pulmonary arterial hypertension

    Authors: , , , , , , , , , , - Journal of the American College of Cardiology 2004 cited by 1,564

  12. Imatinib Mesylate as Add-on Therapy for Pulmonary Arterial Hypertension

    Authors: , , , , , , , , , , , , , , , , , , - Circulation 2013 cited by 562

  13. 2019 updated consensus statement on the diagnosis and treatment of pediatric pulmonary hypertension: The European Pediatric Pulmonary Vascular Disease Network (EPPVDN), endorsed by AEPC, ESPR and ISHLT

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - The Journal of Heart and Lung Transplantation 2019 cited by 432

  14. Germline selection shapes human mitochondrial DNA diversity

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Catherine Williamson, NIHR BioResource–Rare Diseases, 100,000 Genomes Project–Rare Diseases Pilot, Sofie Ashford, Christopher J. Penkett, Kathleen Stirrups, Augusto Rendon, Willem H. Ouwehand, John R. Bradley, F. Lucy Raymond, Mark Caulfield, Ernest Turro, Patrick F. Chinnery, Aarnoud Huissoon, Abigail Crisp-Hihn, Adam Shaw, Adam J. Mead, Adam P. Levine, Adrian J. Thrasher, Agnieszka Bierżyńska, Ahamad Hassan, Ajith Kumar, Alba Sanchis‐Juan, Alex Richter, Allan Lawrie, Amy Frary, Andrea H. Németh, Andrea Olschewski, Andreas C. Themistocleous, Andrew C. Browning, Andrew Mumford, Andrew M. Schaefer, Andrew Marshall, Andrew O.M. Wilkie, Andrew Peacock, Andrew R. Harper, Andrew R. Webster, Andrew S.C. Rice, Angela Pyle, Ania Koziell, Anna M. Drazyk, Anne M. Kelly, Annette Wagner, Anthony Attwood, Anthony De Soyza, Anthony M. Vandersteen, Anthony T. Moore, Anton Vonk Noordegraaf, Anupama Rao, Archana Herwadkar, Arjan C. Houweling, Arjune Sen, Augusto Rendon, Austen Worth, Barbara Girerd, Bella Madan, Brian T. Wilson, Carmen Bugarin Diz, Carmen Treacy, Carole Brewer, Carolyn Campbell, Carolyn M. Millar, Catherine Roughley, Catherine Titterton, Catherine Williamson, Cecilia Compton, Cesare Danesino, Chantal Thys, Charaka Hadinnapola, Charu Deshpande and 305 more - Science 2019 cited by 251

  15. TNFα drives pulmonary arterial hypertension by suppressing the BMP type-II receptor and altering NOTCH signalling

    Authors: , , , , , , , , , , , , , , - Nature Communications 2017 cited by 230

  16. Primary Pulmonary Hypertension Is Associated With Reduced Pulmonary Vascular Expression of Type II Bone Morphogenetic Protein Receptor

    Authors: , , , , , , - Circulation 2002 cited by 684

  17. Plasma Metabolomics Implicates Modified Transfer RNAs and Altered Bioenergetics in the Outcomes of Pulmonary Arterial Hypertension

    Authors: , , , , , , , , , , , , , , , , , , , , - Circulation 2016 cited by 217

  18. Single-cell RNA sequencing profiling of mouse endothelial cells in response to pulmonary arterial hypertension

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Cardiovascular Research 2021 cited by 143

  19. Identification of rare sequence variation underlying heritable pulmonary arterial hypertension

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Barbara Girerd, Arjan C. Houweling, Luke Howard, Marc Humbert, David G. Kiely, Gábor Kovács, Robert V. MacKenzie Ross, Shahin Moledina, David Montani, Michael Newnham, Andrea Olschewski, Horst Olschewski, Andrew J. Peacock, Joanna Pepke‐Żaba, Inga Prokopenko, Christopher J. Rhodes, Laura Scelsi, Werner Seeger, Florent Soubrier, Dan F. Stein, Jay Suntharalingam, Emilia M. Swietlik, Mark Toshner, David A. van Heel, Anton Vonk Noordegraaf, Quinten Waisfisz, John Wharton, Stephen J. Wort, Willem H. Ouwehand, Nicole Soranzo, Allan Lawrie, Paul D. Upton, Martin R. Wilkins, Richard C. Trembath, Nicholas W. Morrell - Nature Communications 2018 cited by 384

  20. Chloroquine Prevents Progression of Experimental Pulmonary Hypertension via Inhibition of Autophagy and Lysosomal Bone Morphogenetic Protein Type II Receptor Degradation

    Authors: , , , , , , - Circulation Research 2013 cited by 284

  21. HIF2α–arginase axis is essential for the development of pulmonary hypertension

    Authors: , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2016 cited by 183

  22. Using the Plasma Proteome for Risk Stratifying Patients with Pulmonary Arterial Hypertension

    Authors: , , , , , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2021 cited by 81

  23. Cellular and Molecular Basis of Pulmonary Arterial Hypertension

    Authors: , , , , , , , , , , , - Journal of the American College of Cardiology 2009 cited by 812

  24. Inflammation, Growth Factors, and Pulmonary Vascular Remodeling

    Authors: , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2009 cited by 720